Anterra Capital leads financing to advance Invetx’s pipeline of animal biologic drugs leveraging breakthroughs in human biopharma Global biologics CDMO WuXi Biologics makes equity investment and joins as R&D collaborator… Read More
SAN DIEGO, CA, Feb. 19, 2020 (GLOBE NEWSWIRE) — Emerald Health Pharmaceuticals Inc. (EHP), a clinical-stage pharmaceutical company developing medicines based on cannabinoid science, has been accepted to make two… Read More
Hillel Bachrach, Jason Camm and Zafrira Avnur join EnClear Therapies Board of Directors Investors include 20/20 HealthCare Partners, Amgen Ventures, Peter Thiel, Global Health Sciences (GHS) Fund, Christian Angermayer’s Presight… Read More
Company Anticipates Earlier Than Expected Preliminary Data Readout in August 2020 SAN DIEGO, Feb. 19, 2020 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on… Read More
Commenced Dosing of Patients in Phase 1 Clinical Trial with INM-755 Vancouver, BC – February 14, 2020 – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a clinical stage… Read More
